TirosintSOL 200 ug per 1 mL solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants IBSA Pharma Inc. names for other drugs.

Recalls

• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220409, Exp. 10/2023; 220956, Exp. 03/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220413, Exp. 10/2023; 220964, Exp. 3/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220855, Exp. 2/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220416, Exp. 10/2023; 221053, Exp. 4/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220856, Exp. 2/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220552, Exp. 11/2023; 221055, Exp. 04/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220553, Exp. 11/2023; 221056, Exp. 04/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220407, Exp. 10/2023; 220960, Exp. 03/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220556, Exp. 11/2023; 221058, Exp. 04/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220853, Exp. 02/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220411, Exp. 10/2023; 220854, Exp. 02/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220414, Exp. 10/2023; 220852, Exp. 02/2024; 220970, Exp. 03/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220415, Exp. 10/2023; 221052, Exp. 04/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220959, Exp. 3/2024.
• Jan 30, 2023 · Class II · Ibsa Pharma Inc
  Subpotent Drug
  Lots: Lot #: 220418, Exp. 10/2023; 220560, Exp. 11/2023.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Levothyroxine: every company that makes it

Form

solution, oral

Strength

200 ug per 1 mL

Approval

NDA NDA206977

On the market since

Mar 1, 2019

Package NDCs

71858-0160-1 71858-0160-2 71858-0160-4 71858-0160-5 71858-0160-6

Official label

DailyMed (National Library of Medicine), updated Mar 27, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?